Ignite Creation Date:
2025-12-25 @ 4:58 AM
Ignite Modification Date:
2026-01-29 @ 12:14 AM
Study NCT ID:
NCT00115518
Status:
COMPLETED
Last Update Posted:
2011-08-05
First Post:
2005-06-22
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Radiation Plus Cetuximab in Locally Advanced Non-Small Cell Lung Cancer (NSCLC)
Sponsor:
Heidelberg University
Organization:
Organization Data
Organization:
Class:
OTHER
Study ID:
NEAR L-284/2004
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
OTHER
Responsible Party:
Responsible Party Title:
Responsible Party Type:
None
Responsible Party Affiliation:
Old Name:
Klaus Herfarth, MD
Old Organization:
UJniversity of Heidelberg